临床试验
协议(科学)
样本量测定
样品(材料)
药物试验
药物开发
大样本
医学
运筹学
计算机科学
地理
运营管理
药品
统计
替代医学
工程类
数学
药理学
内科学
化学
病理
色谱法
作者
Chi-Tian Chen,Hsiao‐Hui Tsou,Jung-Tzu Liu,Chin‐Fu Hsiao,Fei Chen,Gang Li,K. K. Gordon Lan
出处
期刊:ICSA book series in statistics
日期:2018-01-01
卷期号:: 269-286
标识
DOI:10.1007/978-981-10-7829-3_10
摘要
In recent years, multiregional clinical trial (MRCT)Multiregional clinical trial (MRCT) has become a preferredPreferred terms strategy to develop new medicines. Implementing the same protocol to include subjects from many geographical regions around the world, MRCTs could speed up the patient enrollment, thus resulted in a quicker drug development and obtain faster approval of the drug globally. At the same time, the MRCT strategy is expected to maintain the sample sizeSample size at the similar level, i.e., without significantly driving up the cost and slowing down the speed of the development.
科研通智能强力驱动
Strongly Powered by AbleSci AI